THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma (original) (raw)
References
Abeysinghe HR, Cao Q, Xu J, Pollock S, Veyberman Y, Guckert NL, Keng P and Wang N . (2003). Cancer Genet. Cytogenet., 143, 125–132.
Abeysinghe HR, Pollock SJ, Guckert NL, Veyberman Y, Keng P, Halterman M, Federoff HJ, Rosenblatt JP and Wang N . (2004). Cancer Genet. Cytogenet., 149, 1–10.
Barda-Saad M, Rozenszajn LA, Ashush H, Shav-Tal Y, Ben Nun A and Zipori D . (1999). Exp. Hematol., 27, 834–844.
Bonewald L, Ades EW, Tung E, Marchalonis JJ and Wang AC . (1984). J. Immunogenet., 11, 283–296.
Cavallaro U and Christofori G . (2001). Biochim. Biophys. Acta., 1552, 39–45.
Chan KT and Lung ML . (2004). Cancer Chemother. Pharmacol., 53, 519–526.
Cheng Y, Chakrabarti R, Garcia-Barcelo M, Ha TJ, Srivatsan ES, Stanbridge EJ and Lung ML . (2002). Genes Chromosomes Cancer, 34, 97–103.
Cheng Y, Stanbridge EJ, Kong H, Bengtsson U, Lerman MI and Lung ML . (2000). Genes Chromosomes Cancer, 28, 82–91.
Crawford JM and Barton RW . (1986). Lab. Invest., 54, 122–135.
Diaz-Romero J, Gaillard JP, Grogan SP, Nesic D, Trub T and Mainil-Varlet P . (2005). J. Cell Physiol., 202, 731–742.
Fero ML, Randel E, Gurley KE, Roberts JM and Kemp CJ . (1998). Nature, 396, 177–180.
Li LC and Dahiya R . (2002). Bioinformatics, 18, 1427–1431.
Lin CY, Strom A, Vega VB, Kong SL, Yeo AL, Thomsen JS, Chan WC, Doray B, Bangarusamy DK, Ramasamy A, Vergara LA, Tang S, Chong A, Bajic VB, Miller LD, Gustafsson JA and Liu ET . (2004). Genome Biol., 5, R66.
Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY, Yau WL, Ko JM, Stanbridge EJ and Lung ML . (2004). Int. J. Cancer, 112, 628–635.
Protopopov AI, Li J, Winberg G, Gizatullin RZ, Kashuba VI, Klein G and Zabarovsky ER . (2002). J. Gene Med., 4, 397–406.
Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW and Tao Q . (2004). Oncogene, 23, 4793–4806.